Jorsal, Anders
Pryds, Kasper http://orcid.org/0000-0003-0182-8718
McMurray, John J. V.
Wiggers, Henrik
Sommer, Anders
Nielsen, Jens Cosedis
Nielsen, Roni Ranghøj
Funding for this research was provided by:
Aarhus University
Danish Heart Foundation (11-04-R84-A3234-22641)
Danish Council for Independent Research (11–107461)
Central Denmark Region (1-45-72-4-09)
Eva and Henry Frænkels Foundation
Fabrikant Karl G. Andersens Foundation
Article History
Received: 20 February 2019
Accepted: 13 September 2019
First Online: 26 September 2019
Compliance with ethical standards
:
: Professor John J. V. McMurray’s employer, Glasgow University, has been paid by Novartis for his time spent as Principal Investigator/Executive/Steering Committee member for a number of clinical trials using sacubitril/valsartan and meetings and lectures related to sacubitril/valsartan. The Novo Nordisk Foundation (NNF16OC0018658) financially supports Professor Jens Cosedis Nielsen. The other authors report no conflicts of interest.
: Raw data and statistical coding are available from the corresponding author at kpryds@clin.au.dk